Diagnosis and management of peptic ulcer disease

Clinics in Family Practice

Volumn 6, Issue 3, 2004, Pages 569-587

  Saad, Richard J ^a   Scheiman, James M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BISMUTH SALICYLATE; BISPHOSPHONIC ACID DERIVATIVE; CLARITHROMYCIN; COCAINE; CONTRAST MEDIUM; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE; MISOPROSTOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; POTASSIUM CHLORIDE; PROSTAGLANDIN; PROSTAGLANDIN E1; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR; TETRACYCLINE; TRAMADOL; UNINDEXED DRUG; WARFARIN;

ABDOMINAL CRAMP; AGED; ANTIBIOTIC RESISTANCE; ANTIBODY DETECTION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DYSPEPSIA; ENDOSCOPIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; MEDICAL RECORD; PATHOGENESIS; PEPTIC ULCER; PRIMARY MEDICAL CARE; PROPHYLAXIS; RISK FACTOR; SYMPTOMATOLOGY;

EID: 4344691147     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cfp.2004.03.005     Document Type: Review

References (33)

1. Del Valle J. Acid peptic disorders In: Yamada T. Alpers D.H. (Eds) Textbook of gastroenterology 2003 1322-1376 Lippincott Williams - Wilkins Philadelphia
2. Sonnenberg A. Peptic ulcer In: Everhart J.E. (Eds.) National Digestive Diseases Data Working Group (US) National Institute of Diabetes and Digestive and Kidney Diseases (US) Digestive diseases in the United States: epidemiology and impact 1994 xii US Dept. of Health and Human Services Public Health Service National Institutes of Health Bethesda 799
3. The burden of gastrointestinal diseases 2001 American Gastroenterology Association Baltimore 23-26
4. Gisbert J.P. Blanco M. Mateos J.M. Fernandez-Salazar L. Fernandez-Bermejo M. Cantero J. et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients Dig Dis Sci 44 1999 2295-2302
5. Howden C. Helicobaceter pylori-related peptic ulcer disease: causation, diagnosis, treatment, and complications In: Irvine E. Hunt R. (Eds.) Evidence-based gastroenterology 2002 79-101 BC Decker Hamilton (Ont)
6. Quan C. Talley N.J. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs Am J Gastroenterol 97 2002 2950-2961
7. Straus W.L. Ofman J.J. Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs: epidemiologic and economic issues Gastroenterol Clin North Am 30 2001 895-920
8. Wight N. Hawkey C. Nonsteroidal anti-inflammatory drug-related peptic ulcer disease In: Irvine E. Hunt R. (Eds) Evidence-based gastroenterology 2002 102-118 BC Decker Hamilton (Ont)
9. Derry S. Loke Y.K. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 2000 1183-1187
10. Aldoori W.H. Giovannucci E.L. Stampfer M.J. Rimm E.B. Wing A.L. Willett W.C. A prospective study of alcohol, smoking, caffeine, and the risk of duodenal ulcer in men Epidemiology 8 1997 420-424
11. Chan F.K. Helicobacter pylori and nonsteroidal anti-inflammatory drugs Gastroenterol Clin North Am 30 2001 937-952
12. Hawkey C.J. Jones J.I. Gastrointestinal safety of COX-2 specific inhibitors Gastroenterol Clin North Am 30 2001 921-936
13. Hilton D. Iman N. Burke G.J. Moore A. O'Mara G. Signorini D. et al. Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study Am J Gastroenterol 96 2001 380-384
14. Armstrong D. Dyspepsia: classification, diagnosis, and therapy In: Irvine E. Hunt R. (Eds) Evidence-based gastroenterology 2002 147-183 BC Decker Hamilton (Ont)
15. Talley N.J. Silverstein M.D. Agreus L. Nyren O. Sonnenberg A. Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association Gastroenterology 114 1998 582-595
16. Dyspepsia Mcquaid K. In: Feldman M. Friedman L.S. Sleisenger M.H. Sleisenger - Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management 2002 102-116 Saunders Philadelphia
17. Talley N.J. Dyspepsia Gastroenterology 125 2003 1219-1226
18. American Gastroenterological Association Medical Position Statement Evaluation of dyspepsia Gastroenterology 114 1998 579-581
19. Veldhuyzen van Zanten S.J. Flook N. Chiba N. Armstrong D. Barkun A. Bradette M. et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group CMAJ 162 Suppl 2000 S3-S23
20. Levine M.S. Role of the double-contrast upper gastrointestinal series in the 1990s Gastroenterol Clin North Am 24 1995 289-308
21. AGA Technical Review. Evaluation of Dyspepsia Gastroenterology 114 1998 582-595
22. Longstreth G.F. Long-term costs after gastroenterology consultation with endoscopy versus radiography in dyspepsia Gastrointest Endosc 38 1992 23-26
23. Lee J.M. Breslin N.P. Fallon C. O'Morain C.A. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding Am J Gastroenterol 95 2000 1166-1170
24. Loy C.T. Irwig L.M. Katelaris P.H. Talley N.J. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis Am J Gastroenterol 91 1996 1138-1144
25. Vaira D. Malfertheiner P. Megraud F. Axon A.T. Deltenre M. Gasbarrini G. et al. Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group Am J Gastroenterol 95 2000 925-929
26. Grino P. Pascual S. Such J. Casellas J.A. Niveiro M. Andreu M. et al. Comparison of stool immunoassay with standard methods for detection of Helicobacter pylori infection in patients with upper-gastrointestinal bleeding of peptic origin Eur J Gastroenterol Hepatol 15 2003 525-529
27. Hopkins R.J. Girardi L.S. Turney E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review Gastroenterology 110 1996 1244-1252
28. McMahon B.J. Hennessy T.W. Bensler J.M. Bruden D.L. Parkinson A.J. Morris J.M. et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections Ann Intern Med 139 2003 463-469
29. Megraud F. Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection Aliment Pharmacol Ther 17 2003 1333-1343
30. Hawkey C.J. Langman M.J. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors Gut 52 2003 600-608
31. Chan F.K. Sung J.J. Chung S.C. To K.F. Yung M.Y. Leung V.K. et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers Lancet 350 1997 975-979
32. Chan F.K. Hung L.C. Suen B.Y. Wu J.C. Lee K.C. Leung V.K. et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis N Engl J Med 347 2002 2104-2110
33. Scheiman J.M. Yeomans N. Hawkey C.J. Talley N.J. Gothe L. Sung J. et al. Esomeprazole reduces gastric and duodenal ulcer development among high risk NSAID users American Journal of Gastroenterology 98 2003 S52